Australia appears to be welcome innovative therapy for obesity: Retatrutide. The dual molecule – working on both GLP-1 and GIP receptors – has remarkable efficacy in international trials, indicating substantial drops in body fat. While regulatory clearance hasn't occurred with TGA, a number of people dealing with weight-related health concerns